185 related articles for article (PubMed ID: 9354430)
21. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
22. An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell.
Tsukuda K; Wiewrodt R; Molnar-Kimber K; Jovanovic VP; Amin KM
Cancer Res; 2002 Jun; 62(12):3438-47. PubMed ID: 12067986
[TBL] [Abstract][Full Text] [Related]
23. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
24. In human salivary gland cells, overexpression of E2F1 overcomes an interferon-gamma- and tumor necrosis factor-alpha-induced growth arrest but does not result in complete mitosis.
Lillibridge CD; O'Connell BC
J Cell Physiol; 1997 Sep; 172(3):343-50. PubMed ID: 9284954
[TBL] [Abstract][Full Text] [Related]
25. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy.
Pützer BM; Stiewe T; Crespo F; Esche H
Gene Ther; 2000 Aug; 7(15):1317-25. PubMed ID: 10918503
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status.
Wolf JK; Mills GB; Bazzet L; Bast RC; Roth JA; Gershenson DM
Gynecol Oncol; 1999 Nov; 75(2):261-6. PubMed ID: 10525383
[TBL] [Abstract][Full Text] [Related]
27. E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53.
Pruschy M; Wirbelauer C; Glanzmann C; Bodis S; Krek W
Cell Growth Differ; 1999 Mar; 10(3):141-6. PubMed ID: 10099827
[TBL] [Abstract][Full Text] [Related]
28. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
29. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
30. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells.
Mitlianga PG; Gomez-Manzano C; Kyritsis AP; Fueyo J
Int J Oncol; 2002 Nov; 21(5):1015-20. PubMed ID: 12370749
[TBL] [Abstract][Full Text] [Related]
32. Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis.
Canman CE; Kastan MB
Oncogene; 1998 Feb; 16(8):957-66. PubMed ID: 9519869
[TBL] [Abstract][Full Text] [Related]
33. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
34. Stress signals induce transcriptionally inactive E2F-1 independently of p53 and Rb.
O'Connor DJ; Lu X
Oncogene; 2000 May; 19(20):2369-76. PubMed ID: 10828878
[TBL] [Abstract][Full Text] [Related]
35. Retinoblastoma protein inhibits IFN-gamma induced apoptosis.
Berry DE; Lu Y; Schmidt B; Fallon PG; O'Connell C; Hu SX; Xu HJ; Blanck G
Oncogene; 1996 Apr; 12(8):1809-19. PubMed ID: 8622902
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated N5 gene transfer inhibits tumor cell proliferation by induction of apoptosis.
Yin S; Hung MC; Goodrich DW
Cancer Gene Ther; 2000 Jul; 7(7):985-90. PubMed ID: 10917200
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factor.
Bandara LR; Girling R; La Thangue NB
Nat Biotechnol; 1997 Sep; 15(9):896-901. PubMed ID: 9306407
[TBL] [Abstract][Full Text] [Related]
40. Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus.
Henderson YC; Breau RL; Liu TJ; Clayman GL
Head Neck; 2000 Jul; 22(4):347-54. PubMed ID: 10862017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
